Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR.
Zhou X, Du J, Wang H, Chen C, Jiao L, Cheng X, Zhou X, Chen S, Gou S, Zhao W, Zhai W, Chen J, Gao Y.
Zhou X, et al. Among authors: chen j, chen c, chen s.
Cell Commun Signal. 2020 Sep 7;18(1):142. doi: 10.1186/s12964-020-00638-2.
Cell Commun Signal. 2020.
PMID: 32894141
Free PMC article.